Skip to content

Cambridge MedChem Consulting

Home

News

Drug Discovery Resources

February 16, 2026
  • About
    • Publications
  • News
  • Drug Discovery Resources
  • Target Validation
    • Chemical Probes
  • Hit Identification
    • Directed and Virtual Screening
    • Selecting Compounds from a Virtual Screening Run
    • Examples of Fingerprint and Descriptors
    • Historical Perspective of High-Throughput Screening
    • Privileged Structures
    • Focused Screening Libraries
    • Kinase Inhibitors
    • Aspartic Protease Inhibitors
    • Cysteine Protease Inhibitors
    • Serine Protease Inhibitors
    • Metalloenzyme inhibitors
    • Modulators of Protein-Protein Interactions
    • Frequent Hitters, False Positives, Promiscuous Compounds
    • Aggregation
    • Analysis of high-throughput screening data
    • Encoded Library Technology
    • Macrocycles
    • Macrocycles in the Protein Data Bank
  • Fragment-Based screening
    • Building a Fragment Collection
    • Fragment-Based Screening Published Hits
    • Fragments and Novelty
  • Lead Identification
    • Physicochemical Properties
    • Lipophilicity
    • Solubility
  • Lead Optimisation
    • Bioisosteric Replacements
    • Simple Bioisosteres
    • Acid Bioisosteres
    • GABA Bioisosteres
    • Basic Bioisosteres
    • Carbonyl Bioisosteres
    • Ester amd Amide Bioisosteres
    • Aromatic Bioisosteres
    • Sulphonamide Bioisosteres
    • Phosphate Bioisosteres
    • Metal Chelation in Enzyme Active Sites
    • Structure-based design
    • Molecular Interactions
    • Solvation and Desolvation.
    • Separation of PK and PD
  • ADME/T Properties
    • Absorption and Bioavailability
    • Distribution and Plasma Protein Binding
    • Half Life
    • Transporters
    • ABCB1 also known as P-gp and MDR1
    • Brain Penetration
    • Metabolism
    • Cytochrome P450 interactions
    • Enzyme Induction
    • Cytochrome 1A2 inhibition
    • Cytochrome 2C9 inhibition
    • Cytochrome 2C19 Inhibition
    • Cytochrome 2D6 inhibition
    • Cytochrome 3A4 inhibition
    • Aldehyde Oxidase
    • Formulation
  • Pre-Clinical Toxicity
    • Human Ether-a-go-go-Related Gene (hERG) Blockers
    • Mutagenicity
    • Hepatotoxicity
    • Idiosyncratic toxicity
  • Computational Tools
    • Predicting Binding affinity
    • Predicting Off-target activity
    • Predicting Metabolism
    • Chemistry and Biology Databases
  • Covalent Inhibitors
  • PROteolysis TArgeting Chimeras (PROTACs)
  • Candidate Selection
  • Thinking about grant funding your research?
  • Miscellaneous
    • Vaccinations
    • Drug Discovery Books
    • European Lead Factory
    • RSC CICAG/RSC BMCS 20 Years of the Rule of Five Meeting
    • New Approaches to the Treatment of Parkinson’s Disease

Vaccinations

Written by

cjs007

in

vaccinations

I’ve updated the page on Vaccinations

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook

Like this:

Like Loading…

Share this article

  • Share on Bluesky (Opens in new window)Bluesky
  • Share on LinkedIn (Opens in new window)LinkedIn
  • Share on Mastodon (Opens in new window)Mastodon
←MHRA launches AI sandbox to accelerate medicines development and improve safety
OpenADMET update→

More posts

  • An Updated Jupyter Notebook for docking

    October 24, 2026
  • AI for Drug Discovery

    October 9, 2026
  • BMCS New Approaches to Neurodegenerative Diseases

    October 7, 2026
  • Modelling hERG Channel Liability

    September 12, 2026
  • Contact
  • LinkedIn
  • Mail

Designed with WordPress

%d